NBIX vs SATA
Neurocrine Biosciences Inc (NBIX) versus Strive, Inc. Variable Rate Series A Perpetual Preferred Stock (SATA) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Strive, Inc. Variable Rate Series A Perpetual Preferred Stock (SATA) is a asset management company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
SATA does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SATA currently screens at market cap $0.
Not investment advice. Open the NBIX and SATA stock pages for the full models.
Not investment advice.